These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35429639)

  • 1. Prevalence and risk factors of tigecycline-induced liver injury: A multicenter retrospective study.
    Yu Z; Zhao Y; Jin J; Zhu J; Yu L; Han G
    Int J Infect Dis; 2022 Jul; 120():59-64. PubMed ID: 35429639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data.
    Wei C; Liu Y; Jiang A; Wu B
    Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM.
    Shi X; Zuo C; Yu L; Lao D; Li X; Xu Q; Lv Q
    Front Pharmacol; 2021; 12():761167. PubMed ID: 34795591
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
    Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale.
    Shi X; Lao D; Xu Q; Li X; Lv Q
    BMC Infect Dis; 2022 Apr; 22(1):368. PubMed ID: 35410140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for amiodarone-induced liver injury: A retrospective analysis of medical records.
    Nagai H; Amemiya T; Suzuki H
    Int J Clin Pharmacol Ther; 2023 Oct; 61(10):455-459. PubMed ID: 37548459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury.
    Tan K; Yang W; Pang L; Hou F
    Medicine (Baltimore); 2022 Aug; 101(32):e29909. PubMed ID: 35960048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan.
    Suzuki N; Noh JY; Hiruma M; Kawaguchi A; Morisaki M; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Iwaku K; Yoshihara A; Watanabe N; Sugino K; Ito K
    Thyroid; 2019 Oct; 29(10):1390-1398. PubMed ID: 31573408
    [No Abstract]   [Full Text] [Related]  

  • 10. The progression of chronicity and autoimmune hepatitis in recurrent drug-induced liver injury.
    He T; Ren L; Gong M; Guo Y; Wang L; Xiao X; Wang R; Bai Z
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102009. PubMed ID: 35977662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Tigecycline-Associated Hepatotoxicity in Patients in the Intensive Care Units of 2 Tertiary Hospitals: A Retrospective Study.
    Jiang T; Huang X; Liu Q; Feng H; Huang Y; Lin J; Huang L; Chen S; Zhuang Y; Weng C
    J Clin Pharmacol; 2022 Nov; 62(11):1426-1434. PubMed ID: 35670488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.
    Shen T; Liu Y; Shang J; Xie Q; Li J; Yan M; Xu J; Niu J; Liu J; Watkins PB; Aithal GP; Andrade RJ; Dou X; Yao L; Lv F; Wang Q; Li Y; Zhou X; Zhang Y; Zong P; Wan B; Zou Z; Yang D; Nie Y; Li D; Wang Y; Han X; Zhuang H; Mao Y; Chen C
    Gastroenterology; 2019 Jun; 156(8):2230-2241.e11. PubMed ID: 30742832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An analysis on clinical characteristics and prognosis-related risk factors in patients with drug-induced liver injury].
    Wei Q; Li L; Zeng XQ; Abidan BHTYE; Yin J; Gao H; Guo JS
    Zhonghua Gan Zang Bing Za Zhi; 2024 Mar; 32(3):214-221. PubMed ID: 38584102
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Features and Risk Factors for Drug-Induced Liver Injury: A Retrospective Study From China.
    Ma X; Chen Z; An J; Zhang C
    Clin Ther; 2024 Aug; 46(8):597-603. PubMed ID: 38821767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin-converting enzyme inhibitor.
    Thi Thu PN; Quynh MNT; Van HN; Thanh HN; Minh KP
    PLoS One; 2022; 17(8):e0272786. PubMed ID: 35976917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.
    Fontana RJ; Hayashi PH; Gu J; Reddy KR; Barnhart H; Watkins PB; Serrano J; Lee WM; Chalasani N; Stolz A; Davern T; Talwakar JA;
    Gastroenterology; 2014 Jul; 147(1):96-108.e4. PubMed ID: 24681128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of drug-induced liver injury in medical inpatients.
    Meier Y; Cavallaro M; Roos M; Pauli-Magnus C; Folkers G; Meier PJ; Fattinger K
    Eur J Clin Pharmacol; 2005 Apr; 61(2):135-43. PubMed ID: 15726344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China.
    Tuohutaerbieke M; Li X; Yin Y; Chen W; Wu D; Mao Z; Mamuerjiang J; Mao Y; Shen T
    Front Pharmacol; 2021; 12():657805. PubMed ID: 34040524
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.